Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
EMV Capital plc is a prominent venture capital investment group founded in 2018 and headquartered in London, with additional offices in Cambridge. The firm is publicly quoted on the AIM market of the London Stock Exchange, which underscores its commitment to transparency and investor engagement. EMV Capital specializes in investing in early-stage companies that possess attractive intellectual property, particularly within the deep tech and life sciences sectors. With a focus on generating superior returns for its investors, EMV Capital employs a strategic investment approach that includes capital-efficient investments through its PLC balance sheet, fund management of the Evergreen EIS and Martlet Capital Funds, and syndicated investments leveraging a network of third-party investors. The firm is recognized for its proactive management style, which aims to strengthen portfolio companies from their inception through to successful exits.
EMV Capital's investment focus is primarily on early-stage companies operating within the deep tech and life sciences sectors. The firm seeks to identify and support companies that demonstrate strong intellectual property and innovative technologies. Their investment strategy is characterized by capital-efficient investments, which are facilitated through their PLC balance sheet, as well as through the management of the Evergreen EIS and Martlet Capital Funds. EMV Capital also engages in syndicated investments, collaborating with a network of third-party investors to enhance their capital deployment. The firm emphasizes proactive management and value creation services, ensuring that portfolio companies receive the necessary support to navigate their growth journey effectively. By focusing on sectors such as biotechnology and healthcare, EMV Capital aims to back companies that are not only poised for growth but also have the potential to make significant impacts in their respective fields.
EMV Capital manages a diverse portfolio of over 70 companies, showcasing its commitment to investing in high-potential ventures. Notable investments include PDS Biotechnology, a NASDAQ-listed company that focuses on harnessing the immune system to combat cancer; Glycotest, which is developing innovative blood tests for liver diseases; and Sofant Technologies, specializing in advanced antenna technology. Other significant portfolio companies include EpiBone, which is advancing skeletal reconstruction through 3D design and living cells; Vortex, known for its innovative solutions in biotechnology; and Wanda Health, which focuses on healthcare technology solutions. This diverse array of investments highlights EMV Capital's strategic approach to supporting companies that are at the forefront of technological advancement and healthcare innovation.
To pitch EMV Capital, founders should visit their website at emvcapital.com or email info@emvcapital.com. They encourage pitches that clearly articulate the business model and market opportunity. EMV Capital is open to both warm introductions and cold applications, but a well-prepared pitch is essential for consideration.
EMV Capital primarily invests in early-stage companies, specifically at the Pre Seed, Seed, and Seed Plus stages. This focus allows them to engage with startups at critical points in their development, providing the necessary capital and support to foster growth.
Founders interested in pitching to EMV Capital can do so through their website at emvcapital.com or by emailing info@emvcapital.com. They welcome pitches that clearly outline the business model, market opportunity, and the unique value proposition of the startup.
EMV Capital focuses on the deep tech and life sciences sectors. They are particularly interested in companies that possess strong intellectual property and innovative technologies that can drive significant advancements in these fields.
The specific check sizes are not detailed in the source material, but EMV Capital's investment strategy emphasizes capital-efficient investments, suggesting they tailor their financial support to the needs of the portfolio companies.
EMV Capital has a global investment approach, with a particular emphasis on opportunities within Europe and the United Kingdom. This geographic focus allows them to tap into a rich ecosystem of innovation and technology.
The application process involves submitting a pitch through their website or via email. Founders should ensure their pitch includes comprehensive details about their business, market potential, and how they align with EMV Capital's investment focus.
EMV Capital emphasizes proactive management and value creation services for its portfolio companies. This support is designed to help startups navigate their growth journey effectively, from early stages through to successful exits.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.